Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
February 28, 2025 02:42 ET | Source: Nxera Pharma Daridorexant is a…
undefined
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
February 27, 2025 19:05 ET | Source: Nxera Pharma Cenerimod is a…
undefined
Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia
December 18, 2024 21:35 ET | Source: Nxera Pharma Tokyo, Japan and…
undefined